FI62077C - Foerfarande foer framstaellning av farmaceutiskt anvaendbara fenoximetylpiperidinopropanolderivat - Google Patents

Foerfarande foer framstaellning av farmaceutiskt anvaendbara fenoximetylpiperidinopropanolderivat Download PDF

Info

Publication number
FI62077C
FI62077C FI773346A FI773346A FI62077C FI 62077 C FI62077 C FI 62077C FI 773346 A FI773346 A FI 773346A FI 773346 A FI773346 A FI 773346A FI 62077 C FI62077 C FI 62077C
Authority
FI
Finland
Prior art keywords
group
propoxy
phenoxymethyl
hydroxy
piperidino
Prior art date
Application number
FI773346A
Other languages
English (en)
Finnish (fi)
Other versions
FI773346A (fi
FI62077B (fi
Inventor
Wolfgang Kampe
Walter-Gunar Friebe
Fritz Wiedemann
Gisbert Sponer
Wolfgang Bartsch
Karl Dietmann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762651574 external-priority patent/DE2651574A1/de
Priority claimed from DE19772737630 external-priority patent/DE2737630A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of FI773346A publication Critical patent/FI773346A/fi
Application granted granted Critical
Publication of FI62077B publication Critical patent/FI62077B/fi
Publication of FI62077C publication Critical patent/FI62077C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI773346A 1976-11-12 1977-11-08 Foerfarande foer framstaellning av farmaceutiskt anvaendbara fenoximetylpiperidinopropanolderivat FI62077C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19762651574 DE2651574A1 (de) 1976-11-12 1976-11-12 Ein neues aminopropanol-derivat und verfahren zu dessen herstellung
DE2651574 1976-11-12
DE19772737630 DE2737630A1 (de) 1977-08-20 1977-08-20 Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2737630 1977-08-20

Publications (3)

Publication Number Publication Date
FI773346A FI773346A (fi) 1978-05-13
FI62077B FI62077B (fi) 1982-07-30
FI62077C true FI62077C (fi) 1982-11-10

Family

ID=25771134

Family Applications (1)

Application Number Title Priority Date Filing Date
FI773346A FI62077C (fi) 1976-11-12 1977-11-08 Foerfarande foer framstaellning av farmaceutiskt anvaendbara fenoximetylpiperidinopropanolderivat

Country Status (23)

Country Link
US (1) US4146630A (xx)
JP (1) JPS5363385A (xx)
AR (3) AR218643A1 (xx)
AT (1) AT361476B (xx)
AU (1) AU510284B2 (xx)
CA (1) CA1086740A (xx)
CH (3) CH636099A5 (xx)
CS (1) CS228106B2 (xx)
DD (1) DD133801A5 (xx)
DK (1) DK500677A (xx)
ES (2) ES472747A1 (xx)
FI (1) FI62077C (xx)
FR (1) FR2370744A1 (xx)
GB (1) GB1541547A (xx)
HU (1) HU177410B (xx)
IL (1) IL53323A (xx)
IT (1) IT1087490B (xx)
LU (1) LU78498A1 (xx)
NL (1) NL7712220A (xx)
PL (2) PL112683B1 (xx)
SE (1) SE7712720L (xx)
SU (2) SU826955A3 (xx)
YU (3) YU266477A (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314943A (en) * 1977-07-13 1982-02-09 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
US4495352A (en) * 1979-02-13 1985-01-22 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
DE2905876A1 (de) * 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue piperidinopropylderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2922084A1 (de) * 1979-05-31 1980-12-11 Boehringer Mannheim Gmbh Neue aminopropanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3200304A1 (de) * 1981-01-16 1982-08-26 Sandoz-Patent-GmbH, 7850 Lörrach 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
WO1985004580A1 (en) * 1984-04-09 1985-10-24 American Hospital Supply Corporation Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders
FR2574795B1 (fr) * 1984-12-18 1987-11-20 Ile De France Nouveau procede industriel de synthese du n-((1'-allyl 2'-pyrrolidinyl) methyl) 2-methoxy 4,5-azimido benzamide
US5789402A (en) * 1995-01-17 1998-08-04 Eli Lilly Company Compounds having effects on serotonin-related systems
US5614523A (en) * 1995-01-17 1997-03-25 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5741789A (en) 1995-01-17 1998-04-21 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5627196A (en) * 1995-01-17 1997-05-06 Eli Lilly And Company Compounds having effects on serotonin-related systems
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
WO2010059393A1 (en) * 2008-10-30 2010-05-27 Janssen Pharmaceutica Nv Serotonin receptor modulators
WO2010059390A1 (en) 2008-10-30 2010-05-27 Janssen Pharmaceutica Nv Modulators of serotonin receptor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB925429A (en) * 1960-04-01 1963-05-08 Irwin Neisler & Co Indole derivatives
US3699123A (en) * 1970-03-24 1972-10-17 Sandoz Ltd 4-(3-amino-2-hydroxy-propoxy) indole derivatives
BE794333A (fr) * 1972-01-20 1973-07-19 Wyeth John & Brother Ltd Composes heterocycliques azotes therapeutiques
JPS517672B2 (xx) * 1972-04-13 1976-03-10
JPS6024100B2 (ja) * 1975-02-11 1985-06-11 ベーリンガー・マンハイム・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング アミノプロパノ−ル−誘導体の製法
DE2549568C3 (de) * 1975-11-05 1981-10-29 Bayer Ag, 5090 Leverkusen 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel

Also Published As

Publication number Publication date
CS228106B2 (en) 1984-05-14
JPS5363385A (en) 1978-06-06
SE7712720L (sv) 1978-05-13
PL110782B1 (en) 1980-07-31
CH643554A5 (de) 1984-06-15
ES472747A1 (es) 1979-02-16
AT361476B (de) 1981-03-10
FR2370744B1 (xx) 1981-06-12
IL53323A0 (en) 1978-01-31
YU128883A (en) 1984-04-30
DK500677A (da) 1978-05-13
AR218643A1 (es) 1980-06-30
PL112683B1 (en) 1980-10-31
AU3046677A (en) 1979-05-17
YU128983A (en) 1984-04-30
LU78498A1 (xx) 1979-02-02
AU510284B2 (en) 1980-06-19
CH639086A5 (de) 1983-10-31
PL201997A1 (pl) 1979-03-12
CA1086740A (en) 1980-09-30
GB1541547A (en) 1979-03-07
FR2370744A1 (fr) 1978-06-09
ES472746A1 (es) 1979-02-16
SU826955A3 (ru) 1981-04-30
SU890975A3 (ru) 1981-12-15
US4146630A (en) 1979-03-27
AR221081A1 (es) 1980-12-30
FI773346A (fi) 1978-05-13
CH636099A5 (de) 1983-05-13
AR221868A1 (es) 1981-03-31
IL53323A (en) 1981-12-31
YU266477A (en) 1984-02-29
JPS6341910B2 (xx) 1988-08-19
NL7712220A (nl) 1978-05-17
FI62077B (fi) 1982-07-30
ATA808277A (de) 1980-08-15
IT1087490B (it) 1985-06-04
DD133801A5 (de) 1979-01-24
HU177410B (en) 1981-10-28

Similar Documents

Publication Publication Date Title
FI62077C (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara fenoximetylpiperidinopropanolderivat
US5786355A (en) 4,6-diarylpyrimidine derivatives and salts thereof
US6093735A (en) Selective β-3 adrenergic agonists
FI93012C (fi) Menetelmä terapeuttisesti käyttökelpoisten (1-hydroksi-2-piperidinoalkyyli)-2-indoloni-, 2-kinoloni-, 2-bentso/b/-atsepinoni-, bentsimidatsoloni- ja 2-kinatsolinonijohdannaisten valmistamiseksi
US6075040A (en) Selective β3 adrenergic agonists
NO144262B (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme n-substituerte benzamidderivater
BG61946B1 (bg) Хетеробициклични съединения
US5182280A (en) Derivatives of benzimidazole and their use as antihistamines
US5006570A (en) Dihydrobenzofuran- and chroman-carboxamide derivatives, processes for the preparation thereof and use thereof as neuroleptics
US5286735A (en) Derivatives of 4-aminomethylpiperidine, their preparation and their use as therapeutics
HU215833B (hu) Szubsztituált (kinolin-2-il-metoxi)-fenil-acil-szulfonamidok és -ciánamidok, és ezeket tartalmazó gyógyszerkészítmények, és eljárás ezek előállítására
CA2312987A1 (en) Selective .beta.3 adrenergic agonists
US5356906A (en) (N-phthalimidoalkyl) piperidines useful as treatments for psychosis
DE4105551A1 (de) 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE2737630C2 (xx)
SU1041033A3 (ru) Способ получени производных аминопропанола или их солей
IE922090A1 (en) 2-(1-piperidyl)ethanol derivatives, their preparation and¹their therapeutic application
US4442102A (en) 1,5-Diphenylpyrazolin-3-one compounds, process and intermediates for preparation thereof and pharmaceutical compositions containing same
NO164899B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
EP1786801B1 (en) 2-arylcarbamoyl-indoles as cytokine inhibitors
US4537975A (en) 1-Phenylindazol-3-one compounds
US5013734A (en) Novel esters of phenylalkanoic acid
US4885299A (en) 2-(2,3-dihydro-2-oxo-3-benzofuranyl)acetic acids antihypoxic and nootropic effects having
US4434174A (en) Treating cardiovascular diseases with N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
CS228109B2 (cs) Způsob výroby nových derivátů 3-(4-fenoxymethylpiperidino)propanolu

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BOEHRINGER MANNHEIM GMBH